Article
DNA repair genes in astrocytoma tumorigenesis, progression and therapy resistance
13 Dec 2019
Abstract excerpt
Glioblastoma (GBM) is the most common and malignant type of primary brain tumor, showing rapid development and resistance to therapies. On average, patients survive 14.6 months after diagnosis and less than 5% survive five years or more. Several pieces of evidence have suggested that the DNA damage signaling and repair activities are directly correlated with GBM phenotype and exhibit opposite functions in cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
